A comprehensive view of neurological/cognitive health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Neurogene announces FDA clearance of IND for NGN-401 gene therapy for children with Rett syndrome; Rett syndrome is an X-linked, progressive, neurodevelopmental disorder that affects 1 in 10,000 live female births
Published: January 23, 2023 by Business Wire
Eli Lilly reports FDA has rejected accelerated approval for its donanemab Alzheimer’s drug due to insufficient data from patients who used the drug for a year; donanemab removes amyloid protein plaques from the brains of people with early Alzheimer's
Published: January 20, 2023 by International Business Times
Reunion Neuroscience appoints Robert Alexander, M.D. as Chief Medical Officer; Dr. Alexander previously served as VP and Head of Clinical Science in the Neuroscience Therapeutic Area Unit at Takeda Pharmaceuticals
Published: January 18, 2023 by GlobeNewswire
Mintel: In 2023, consumers to seek food/drink that helps with cognitive capacity, managing stress, optimizing brain function; other trends include experiential eating, meat substitutes, food for weather-related disasters, female health food, upcycled food
Published: January 10, 2023 by Courier Mail
FDA grants accelerated approval to Biogen and Eisai's anti-amyloid beta protofibril antibody candidate Leqembi lecanemab to treat early Alzheimer's disease; Eisai has set wholesale acquisition cost for the drug at US$26,500 per year
Published: January 10, 2023 by Zack's Commentary

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count